Skip to content

Chitosan effect on gum disease

The effect of chitisan photoactivatable bioactive nanoparticles on nonsurgical management of stage I and II periodontitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20080914001248N8
Enrollment
60
Registered
2020-03-22
Start date
2018-11-22
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic periodontitis stage I and II. Chronic periodontitis

Interventions

Intervention 1: Intervention group: After completing the initial scaling and root planing, a few drops of 0.5 mg / ml Rose Bengal solution and then a few drops of Chitosan nanoparticle solution will b

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Have good general health. At least one tooth with stage1 periodontitis(initial periodontitis) and stage2 periodontitis(moderate periodontitis) that is with a probing depth of =6mm. This tooth is associated with bleeding on probing(BOP) or gingivitis.

Exclusion criteria

Exclusion criteria: Tooth with other symptoms such as mobility, furcation lesions, defect of ridge , and bone destruction or probe depth that leads to the difficulty and complexity of the treatment. Smokers Pregnant women Females on hormone therapy Those who had received systemic or topical antibiotics and/or anti-inflammatory drugs Those who received surgical or non-surgical periodontal treatment within the past 12 months prior to the enrollment

Design outcomes

Primary

MeasureTime frame
Bleeding on probing. Timepoint: 14 and 90 days after completion of scaling and application of Chitosan nanoparticle solution. Method of measurement: Bleeding within 30 seconds after periodontal probe insertion Michigan O Williams marking.

Secondary

MeasureTime frame
Change of probing depth. Timepoint: Baseline, 14 and 90 days after completion of scaling and application of chitosan nanoparticle solution. Method of measurement: periodontal prob of Michigan O With Williams marking.;Clinical attachment level. Timepoint: Baseline, 14 and 90 days after completion of scaling and application of chitosan nanoparticle solution. Method of measurement: periodontal prob of Michigan O With Williams marking.;Gingival recession. Timepoint: Baseline, 14 and 90 days after completion of scaling and application of chitosan nanoparticle solution. Method of measurement: periodontal prob of Michigan O With Williams marking.;Plaque index. Timepoint: Baseline, 14 and 90 days after completion of scaling and application of chitosan nanoparticle solution. Method of measurement: disclosing agents.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Pourabbas

Tabriz University of Medical Sciences

pourabbas@tbzmed.ac.ir+98 41 3335 5965

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026